Fever, or pyrexia, is a common symptom encountered in clinical practice, often indicating an underlying inflammatory process or infection. It is a complex physiological response with a multitude of potential causes, necessitating a thorough and methodical approach to diagnosis and management.
Pyrexia is defined as a temporary increase in body temperature, often but not always due to illness. It's a protective physiological response that enhances the immune system's ability to fight off infections. The hypothalamus, acting as the body's thermostat, regulates this elevation in response to pyrogens, substances often produced during inflammation or infection.
A comprehensive history and physical examination remain the cornerstone of diagnosing the cause of fever. Laboratory investigations like complete blood count, C-reactive protein, and cultures can provide valuable information. Imaging studies may be warranted in certain cases. The clinician's challenge lies in distinguishing self-limiting conditions from serious illnesses that require immediate intervention.
Management should be directed towards the underlying cause. Symptomatic treatment with antipyretics can be considered for patient comfort, but it's important to note that fever itself is not harmful and may even be beneficial. Antipyretics should not be used to mask symptoms in serious infections. Antibiotics or antivirals may be indicated based on the etiology. Patient education about the nature and course of fever is crucial.
Pyrexia is a common clinical presentation with a wide range of potential underlying causes. A systematic approach to diagnosis, guided by clinical history and examination, is key to identifying the cause and determining the appropriate management strategy. Understanding the physiological basis of fever can help clinicians better manage this common symptom and allay patient fears.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation